Life Science
&
Technology Practice
Today's life science and technology exposures demand specific attention. Whether you are a CRO, medical device manufacturer or pharmaceutical manufacturer your exposures are unique and "the one-size-fits-all" approach will undoubtedly leave you with coverage gaps or deficiencies. If you are a global company your exposures are further complicated especially if you are conducting clinical trials on an international level. Appleby & Wyman can assist you with these exposures and establish a global program through one of our insurance partners. We delight clients and exceed their expectations every day, and that is why Appleby & Wyman has a 98%+ client retention rate.
No matter where you are at in the process, Appleby & Wyman can help enhance your risk management program.
- Pre-Clinical
- Phase I
- Phase II
- Phase III
- FDA Review
- Pharma Manufacturing
- Device Manufacturing
Do you know what your policy covers? What does it exclude? How does it compare with other insurance company forms? Let Appleby & Wyman help you successfully navigate through these issues and support the core competencies of your organization.
Finally there is an
alternative value-added insurance brokerage firm focused on providing expert
consultative advice and legendary service to the biotechnology industry.
|